6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid derivatives in a new approach of the treatment of cancer cell invasion and metastasis

被引：53

作者：

Kempen, Isabelle ^{[1
]}

Hemmer, Marc ^{[1
]}

Counerotte, Stephane ^{[1
]}

Pochet, Lionel ^{[2
]}

de Tullio, Pascal ^{[1
]}

Foidart, Jean-Michel ^{[3
]}

Blacher, Silvia ^{[3
]}

Noel, Agnes ^{[3
]}

Frankenne, Francis ^{[3
]}

Pirotte, Bernard ^{[1
]}

机构：

[1] Univ Liege, Lab Chim Pharmaceut, Drug Res Ctr, B-4000 Liege, Belgium

[2] Univ Namur, Dept Pharm, FUNDP, B-5000 Namur, Belgium

[3] Univ Liege, Lab Biol Tumeurs & Dev, B-4000 Liege, Belgium

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 43卷 / 12期

关键词：

Coumarin derivatives; Cancer; Cell invasion; Anti-cancer drug;

D O I：

10.1016/j.ejmech.2008.01.024

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Novel 6-substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid derivatives were synthesized and their potency in reducing the invasive behaviour of HT 1080 fibrosarcoma cells was evaluated. Structure-activity relationships were deduced from biological results and will be used in further design of new active compounds. In particular, the acetoxymethyl substituent found at the 6-position of previously described active compounds can be replaced by an acetamidomethyl substituent without loss of potency; while the presence of an aryl ester function at the 3-position was preferred to a thioester or an amide function to induce marked biological activity. This work confirms the interest of aryl esters of 6-substituted coumarin-3-carboxylic acids as potential new anti-cancer agents. (C) 2008 Elsevier Masson SAS. All rights reserved.

引用

页码：2735 / 2750

页数：16

共 24 条

[1] Targeting angiogenesis for the treatment of sarcoma [J].

Balasubramanian, Lakshmi ;

Evens, Andrew M. .

CURRENT OPINION IN ONCOLOGY, 2006, 18 (04) :354-359

[2] Sunitinib: A newly approved small-molecule inhibitor of angiogenesis [J].

Cabebe, Elwyn ;

Wakelee, Heather .

DRUGS OF TODAY, 2006, 42 (06) :387-398

[3] Antiangiogenic drugs in non-small cell lung cancer treatment [J].

Cascone, T ;

Troiani, T ;

Morelli, MP ;

Gridelli, C ;

Ciardiello, F .

CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) :151-155

[4] An improved synthesis of the selective matrix metal metalloproteinase inhibitor, Ro 28-2653 [J].

Daniewski, AR ;

Liu, W ;

Okabe, M .

ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2004, 8 (03) :411-414

[5] Crystal structure and conformation of Linomide [N-methyl-N-phenyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide]:: A novel immunomodulator [J].

Dasari, KB ;

Srikrishnan, T .

JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, 2002, 32 (12) :499-504

[6] Angiogenesis inhibitors in lung cancer: A promise fulfilled [J].

Dy, Grace K. ;

Adjei, Alex A. .

CLINICAL LUNG CANCER, 2006, 7 :S145-S149

[7] Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells [J].

Finn, G ;

Creaven, B ;

Egan, D .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 481 (2-3) :159-167

[8] Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors [J].

Han, SL ;

Zhou, V ;

Pan, SF ;

Liu, Y ;

Hornsby, M ;

McMullan, D ;

Klock, HE ;

Haugen, J ;

Lesley, SA ;

Gray, T ;

Caldwell, J ;

Gu, XJ .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (24) :5467-5473

[9]

Joseph IBJK, 1996, CANCER RES, V56, P3404

[10] 3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo [J].

Kempen, I ;

Papapostolou, D ;

Thierry, N ;

Pochet, L ;

Counerotte, S ;

Masereel, B ;

Foidart, JM ;

Reboud-Ravaux, M ;

Noël, A ;

Pirotte, B .

BRITISH JOURNAL OF CANCER, 2003, 88 (07) :1111-1118

← 1 2 3 →